SL
Siren LLC Portfolio holdings
AUM
$1.93B
This Quarter Return
-13.7%
1 Year Return
+118.08%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$1.77B
AUM Growth
-$491M
(-22%)
Cap. Flow
-$3.84M
Cap. Flow
% of AUM
-0.22%
Top 10 Holdings %
Top 10 Hldgs %
50.37%
Holding
140
New
23
Increased
28
Reduced
41
Closed
24
Top Buys
| 1 |
BPMC
Blueprint Medicines
BPMC
|
$64.3M |
| 2 |
Disc Medicine
IRON
|
$53.2M |
| 3 |
Soleno Therapeutics
SLNO
|
$26.8M |
| 4 |
Edgewise Therapeutics
EWTX
|
$21.2M |
| 5 |
Rhythm Pharmaceuticals
RYTM
|
$14.7M |
Top Sells
| 1 |
argenx
ARGX
|
$70.8M |
| 2 |
SWTX
SpringWorks Therapeutics
SWTX
|
$49.8M |
| 3 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$42.2M |
| 4 |
Madrigal Pharmaceuticals
MDGL
|
$38.9M |
| 5 |
Cytokinetics
CYTK
|
$18.9M |
Sector Composition
| 1 | Healthcare | 89.75% |
| 2 | Technology | 5.2% |
| 3 | Communication Services | 2.41% |
| 4 | Consumer Discretionary | 1.21% |
| 5 | Real Estate | 0.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Intel
INTC
$105B
| $908K | 0.05% |
40,000
| – | – |
|
102
Informatica
INFA
$7.6B
| $873K | 0.05% |
+50,000
| New | +$873K |
|
103
Boeing
BA
$176B
| $853K | 0.05% |
5,000
-20,000
| -80% | -$3.41M |
|
104
Couchbase
BASE
$1.35B
| $785K | 0.04% |
49,850
-10,150
| -17% | -$160K |
|
|
AGEN
105
Agenus
AGEN
$136M
| $753K | 0.04% |
+500,000
| New | +$753K |
|
|
KRON
106
DELISTED
Kronos Bio
KRON
| $695K | 0.04% |
842,954
| – | – |
|
107
Procore
PCOR
$10.3B
| $660K | 0.04% |
10,000
-10,000
| -50% | -$660K |
|
108
Ferrari
RACE
$88.2B
| $636K | 0.04% |
1,500
-500
| -25% | -$212K |
|
|
HOOK
109
DELISTED
HOOKIPA Pharma
HOOK
| $612K | 0.03% |
566,640
| – | – |
|
110
Deckers Outdoor
DECK
$18.3B
| $559K | 0.03% |
+5,000
| New | +$559K |
|
111
US Bancorp
USB
$75.5B
| $528K | 0.03% |
+12,500
| New | +$528K |
|
112
Occidental Petroleum
OXY
$45.6B
| $494K | 0.03% |
10,000
-5,000
| -33% | -$247K |
|
113
GDS Holdings
GDS
$6.54B
| $317K | 0.02% |
+12,500
| New | +$317K |
|
114
Cyclerion Therapeutics
CYCN
$7.77M
| $290K | 0.02% |
116,155
| – | – |
|
115
Ironwood Pharmaceuticals
IRWD
$201M
| $162K | 0.01% |
110,532
| – | – |
|
116
Caribou Biosciences
CRBU
$176M
| $96.2K | 0.01% |
105,347
| – | – |
|
|
117
argenx
ARGX
$44.2B
| – | – |
-115,045
| Closed | -$70.8M |
|
118
Kanzhun
BZ
$11.1B
| – | – |
-25,000
| Closed | -$345K |
|
|
119
Cytokinetics
CYTK
$5.98B
| – | – |
-402,323
| Closed | -$18.9M |
|
120
Dollar Tree
DLTR
$20.8B
| – | – |
-10,000
| Closed | -$749K |
|
121
Elastic
ESTC
$9.17B
| – | – |
-25,000
| Closed | -$2.48M |
|
122
Freeport-McMoran
FCX
$66.3B
| – | – |
-75,000
| Closed | -$2.86M |
|
123
HCA Healthcare
HCA
$95.4B
| – | – |
-3,750
| Closed | -$1.13M |
|
124
Ionis Pharmaceuticals
IONS
$9.64B
| – | – |
-250,000
| Closed | -$8.74M |
|
125
Iovance Biotherapeutics
IOVA
$800M
| – | – |
-1,106,040
| Closed | -$8.18M |
|